Prospective study of fluconazole therapy in systemic neonatal fungal infection

Pediatric Infectious Disease Journal

Volumn 16, Issue 8, 1997, Pages 763-767

  Wainer, Stephen ^a   Cooper, Peter A ^b   Gouws, Hermien ^b   Akierman, Albert ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE

Author keywords

Candidiasis; Fluconazole; Fungi; Neonatal

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MYCOSIS; NEWBORN; PRIORITY JOURNAL; SYSTEMIC MYCOSIS;

ANTIFUNGAL AGENTS; FEMALE; FLUCONAZOLE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYCOSES; PROSPECTIVE STUDIES;

EID: 0030855792     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199708000-00007     Document Type: Article

References (24)

1. Johnson DE, Thompson TR, Green TP, et al. Systemic candidiasis in very low birth weight infants (<1500 gm). Pediatrics 1984;73:138-43.
2. Baley JE. Neonatal candidiasis: the current challenge. Clin Perinatol 1991;18:263-80.
3. Medoff G, Kobayaski GS. Strategies in the treatment of systemic fungal infections. N Engl J Med 1980;302:145-55.
4. Infectious Diseases and Immunization Committee, Canadian Pediatric Society. Ketoconazole. Can Med Assoc J 1985;133: 1117-8.
5. Van den Anker JN, Van Lingen RA, Koster M, et al. Insufficient ketoconazole concentrations in preterm infants with fungal infections [Letter]. Eur J Pediatr 1993;152:538.
6. Dudley MN. Clinical pharmacology of fluconazole. Pharmacotherapy 1990;10:141S-145S.
7. Viscoli C, Castagnola E, Corsini M, et al: Fluconazole therapy in an underweight infant. Eur J Clin Microbiol Infect Dis 1989;8:925.
8. Grant SM, Clissold SP. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990;39: 877-916.
9. Lee JW, Seibel NL, Amantea M, et al. Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. J Pediatr 1992;120:987-93.
10. Saxen H, Hoppu K, Pohjavuori M. Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Clin Pharmacol Ther 1993;54:269-77.
11. Faix RG. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr 1984;105:616-22.
12. Volpe JJ. Neurology of the newborn. 2nd ed. Philadelphia: Saunders, 1987:596-635.
13. Witman MN, Johnson GM. Fluconazole treatment of disseminated candidiasis in a very-low birth weight Infant. Pediatr Res 1990;27:278A.
14. Viscoli C, Castagnola E, Fioredda F, et al. Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrob Agents Chemother 1991;35:365-7.
15. Fasano C, O'Keeffe J, Gibbs D. Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents. Eur J Clin Microbiol Infect Dis 1994;13:351-4,
16. Brammer KW, Coates PE. Pharmacokinetics of fluconazole in pediatric patients. Eur J Clin Microbiol Infect Dis 1994;13: 325-9.
17. Klein JO, Marcy SM. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 2nd ed. Philadelphia: Saunders, 1983: 679-735.
18. Presterl E, Graninger W. Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Eur J Clin Microbiol Infect Dis 1994;13:347-51.
19. British Society for Antimicrobial Chemotherapy Working Party. Laboratory monitoring of antifungal chemotherapy. Lancet 1991;337:1577-80.
20. Warnock DW, Burke J, Cope NJ, et al. Fluconazole resistance in Candida glabrata [Letter]. Lancet 1988;2:1310.
21. Morace G, Manzara S, Dettori G. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Chemotherapy 1991;37:23-31.
22. Gray G, Wainer S. Drip flagging [Letter]. S Afr Med J 1993;83:298.
23. Wainer S, Khuzwayo H. Attitudes of mothers, doctors, and nurses toward neonatal intensive care in a developing society. Pediatrics 1993;91:1171-5.
24. Driessen M, Ellis JB, Cooper PA, et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J 1996;15:1107-12.